A Case of Rifampin-Induced Crescentic Glomerulonephritis
- Author:
Kyung Nam LEE
1
;
Sang Heon SONG
;
Harin RHEE
;
Eun Young SEONG
;
Il Young KIM
;
Soo Bong LEE
;
Ihm Soo KWAK
Author Information
1. Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea. shsong@pusan.ac.kr
- Publication Type:Case Report
- Keywords:
Rifampin;
Anti-neutrophil cytoplasmic antibodies;
Glomerulonephritis
- MeSH:
Acute Kidney Injury;
Antibodies, Antineutrophil Cytoplasmic;
Biopsy;
Creatinine;
Edema;
Ethambutol;
Glomerulonephritis;
Humans;
Isoniazid;
Male;
Middle Aged;
Nephritis, Interstitial;
Pyrazinamide;
Rifampin;
Steroids;
Tuberculosis, Pulmonary
- From:Korean Journal of Medicine
2012;82(2):236-240
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
A 56-year-old male with pulmonary tuberculosis was admitted to our hospital for evaluation of generalized edema. He began antituberculosis treatment with rifampin, isoniazid, ethambutol, and pyrazinamide. He experienced abnormal increments in weight and serum creatinine after 6 weeks. All serological findings, including anti-neutrophil cytoplasmic antibodies (ANCA), were negative. Rifampin was stopped because it might have caused the increase in creatinine. Renal biopsy was consistent with pauci-immune crescentic glomerulonephritis (CrGN). His renal function was improved by high-dose steroid treatment. Rifampin-induced, ANCA-negative pauci-immune CrGN is very rare; most cases of rifampin-induced acute renal failure are due to acute tubulointerstitial nephritis. We present here a case of rifampin-induced CrGN and pulmonary tuberculosis successfully treated with high-dose steroids and antituberculosis medications, excluding rifampin.
